Clinical Trial Update: Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis. [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating immunoregulation by controlled parasite exposure in multiple sclerosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: University of Nottingham | Conditions: Multiple Sclerosis | Phase 2 | Status: WITHDRAWN